Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
SUN | NSE | INR | Real-time | |
SUNc1:NS | NSE | INR | Delayed | |
SUNc2:NS | NSE | INR | Delayed | |
SUN | BSE | INR | Delayed |
Sun Pharmaceutical Industries Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 120,031.1 million compared to INR 108,091.9 million a year ago. Revenue was INR 124,860.2 million compared to INR 110,375 million a year ago. Net income was INR 23,755.1 million compared to INR 22,622.2 million a year ago. Basic earnings per share from continuing operations was INR 9.9 compared to INR 9.4 a year ago. Diluted earnings per share from continuing operations was INR 9.9 compared to INR 9.4 a year ago.For the six months, sales was INR 237,882.6 million compared to INR 214,531.6 million a year ago. Revenue was INR 246,313 million compared to INR 218,014 million a year ago. Net income was INR 43,980.5 million compared to INR 43,231 million a year ago. Basic earnings per share from continuing operations was INR 18.3 compared to INR 18 a year ago. Diluted earnings per share from continuing operations was INR 18.3 compared to INR 18 a year ago.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 123807 | 121924.1 | 119408.4 | 109306.7 |
Gross Profit | 96437.6 | 94053.2 | 91826.7 | 80239.4 |
Operating Income | 27301.3 | 25806.5 | 26784.1 | 22190.6 |
Net Income | 25237.5 | 23755.1 | 20225.4 | 19844.7 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 794411.6 | 807435.9 | ||
Total Liabilities | 162442.8 | 214281.2 | ||
Total Equity | 631968.8 | 631968.8 | 593154.7 | 593154.7 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | ||||
Cash From Investing Activities | ||||
Cash From Financing Activities | ||||
Net Change in Cash |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review